Gary Rogers, MD
Dermatology · Ocala, FLNPI 1477664480
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $968 of the $1,008 with a category attached, or 96.0%. Regeneron accounts for 96.0% of it on its own, with 2 other manufacturers making up the rest. That places this record below the midpoint for dermatology clinicians in FL, where the typical reported total is $2,563.
Across 3 payments — averaging $336.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$968
- Incyte Corporation$27
- Mimedx Group, Inc.$14
Across 54 payments — averaging $4349.48 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$233K
- F. Hoffmann-la Roche AG$1K
What the payments were for
- Consulting fees$96896%
- Food & beverage$414%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 1 | $968 |
| Incyte Corporation | 1 | $27 |
| Mimedx Group, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LIBTAYO$968
How this compares
$1,008 in reported general payments places this provider in the 30th percentile of 1,147 dermatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mupirocin | 33 | $223 |
| Cephalexin | 30 | $99 |
| Triamcinolone Acetonide | 13 | $87 |
| Oxycodone Hcl | 24 | $51 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Ocala
- Ashley CauthenOcala$288K
- Francisco KerdelMiami$2.1M
- Brad GlickMargate$2M
- Robert KirsnerMiami$1.4M
- John MinniStuart$1.4M
- Gil YosipovitchMiami$1M
- Shino Bay AguileraFt Lauderdale$1M
- Robert SnyderPembroke Pines$1M
- Marc IngleseTallahassee$989K
- Jeremy GreenCoral Gables$952K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.